Highly Curative Treatment of High-Risk Acute Promyelocytic Leukemia: Induction and Consolidation with ATRA+ATO+anthracyclines and Maintenance with ATRA+RIF.

Dan LiuJuan TongErling ChenLi WangLei XueXuhan ZhangNa ZhaoXing HuChang-Cheng Zheng

Published in: Blood and lymphatic cancer : targets and therapy (2024)

For newly diagnosed high-risk APL patients, induction and consolidation with ATRA+ATO+anthracyclines and maintenance with ATRA+RIF is a highly curative treatment approach.

Keyphrases

newly diagnosed
prognostic factors
end stage renal disease
chronic kidney disease
ejection fraction
liver failure
acute myeloid leukemia
combination therapy
intensive care unit
hepatitis b virus
respiratory failure
extracorporeal membrane oxygenation